Biomarkers in Predicting Response to Rituximab Treatment in Samples From Patients With Indolent Follicular Lymphoma
Clinical trial NCT01381705 · COMPLETED
Trial details
- NCT number
- NCT01381705
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-02-06
- Primary completion
- 2012-07-06
- Enrollment
- 259
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.